Skip to main content
- 'Human' insulin versus animal insulin in people with diabetes mellitus
- (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
- (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus
- Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Alpha-glucosidase inhibitors for type 2 diabetes mellitus
- Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
- Angiogenesis-inhibitors for metastatic thyroid cancer
- Antithyroid drug regimen for treating Graves' hyperthyroidism
- Aromatase inhibitors for short stature in male children and adolescents
- Ayurvedic treatments for diabetes mellitus
- Bariatric surgery in adults with obesity and diabetes mellitus: a network meta-analysis
- Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules
- Calcium supplementation for people with overweight or obesity
- Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism
- Chinese herbal medicines for benign thyroid nodules in adults
- Chinese herbal medicines for hypercholesterolemia
- Chinese herbal medicines for hyperthyroidism
- Chinese herbal medicines for hypertriglyceridaemia
- Chinese herbal medicines for hypothyroidism
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
- Chinese herbal medicines for type 2 diabetes mellitus
- Chitosan for overweight or obesity
- Chromium picolinate supplementation for overweight or obese adults
- Cinnamon for diabetes mellitus
- Cognitive behavioural therapy for adults with overweight or obesity
- Colesevelam for type 2 diabetes mellitus
- Computer-assisted versus oral-and-written dietary history taking for diabetes mellitus
- Computer-assisted versus oral-and-written family history taking for identifying people with elevated risk of type 2 diabetes mellitus
- Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
- Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus
- Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents
- Dapagliflozin for adults with type 2 diabetes mellitus
- Definitions and reporting of hypoglycaemia in trials of long-acting insulin analogues in people with type 1 diabetes mellitus
- Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
- Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years
- Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years
- Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years
- Dietary advice for treatment of type 2 diabetes mellitus in adults
- Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
- Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
- Drug interventions for the treatment of obesity in children and adolescents
- Exercise for overweight or obesity
- Exercise for type 2 diabetes mellitus
- Family-based interventions for adults with type 2 diabetes mellitus
- First aid glucose administration routes for symptomatic hypoglycaemia
- Fluoxetine for adults who are overweight or obese
- Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus
- Glucagon-like peptide analogues for type 2 diabetes mellitus
- Glucagon-like peptide-1 analogues for overweight or obese adults
- Green tea for weight loss and weight maintenance in overweight or obese adults
- Group-based self-management education for people with type 2 diabetes mellitus
- Herbal preparations for weight loss in adults
- High versus low dose of initial thyroid hormone replacement for congenital hypothyroidism
- Hormone replacement therapy for women with type 1 diabetes mellitus
- Individual patient education for people with type 2 diabetes mellitus
- Insulin detemir versus insulin glargine for type 2 diabetes mellitus
- Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
- Intermittent fasting for adults with overweight or obesity
- Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus
- Interventions for latent autoimmune diabetes (LADA) in adults
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Interventions for the prevention of nutritional rickets in term born children
- Intragastric balloon for obesity
- Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery
- Iodine supplementation for preventing iodine deficiency disorders in children and adolescents
- Iodised salt for preventing iodine deficiency disorders
- Isoflavones for hypercholesterolaemia in adults
- Levothyroxine or minimally invasive therapies for benign thyroid nodules
- Long-term mono- or dual-combination empagliflozin treatment for adults with type 2 diabetes mellitus
- Long-term non-pharmacological weight loss interventions for adults with prediabetes
- Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus
- Long-term pharmacotherapy for obesity and overweight
- Low glycaemic index or low glycaemic load diets for people with overweight or obesity
- Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
- Low-carbohydrate diet for people with type 2 diabetes mellitus
- Low-fat diets for acquired hypercholesterolaemia
- Meglitinide analogues for type 2 diabetes mellitus
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
- Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Metformin monotherapy for adults with type 2 diabetes mellitus
- Mindfulness-based interventions for adults with type 2 diabetes mellitus
- Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults
- Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity
- Momordica charantia for type 2 diabetes mellitus
- Non-nutritive sweeteners for diabetes mellitus
- Obesity as an independent risk factor for COVID-19 severity and mortality
- Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
- Oral nutrition interventions in hospitalised older people at nutritional risk: a network meta-analysis of individual participant data
- Oral vitamin B versus intramuscular vitamin B for vitamin B deficiency
- Oral vitamin D supplementation for adults with obesity undergoing bariatric surgeryNew
- Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome
- Parathyroidectomy for adults with primary hyperparathyroidism
- Parent-only interventions for childhood overweight or obesity in children aged 5 to 11 years
- Parenteral calcium for intensive care unit patients
- Pentoxifylline for diabetic retinopathy
- Perioperative glycaemic control for people with diabetes undergoing surgery
- Pharmacological and psychosocial interventions for night eating syndrome in adults
- Pharmacological treatments for adults with overweight and obesity without diabetes
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
- Pioglitazone for type 2 diabetes mellitus
- Protein and energy supplementation in elderly people at risk from malnutrition
- Protein restriction for diabetic renal disease
- Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression
- Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus
- Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
- Radioiodine therapy versus antithyroid medications for Graves' disease
- Radioiodine treatment for pediatric Graves' disease
- Recombinant growth hormone for children and adolescents with Turner syndrome
- Recombinant growth hormone for idiopathic short stature in children and adolescents
- Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
- Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre
- Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance
- Resveratrol for adults with type 2 diabetes mellitus
- Rimonabant for overweight or obesity
- Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
- Rosiglitazone for type 2 diabetes mellitus
- Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus
- Screening for type 2 diabetes mellitus
- Self management interventions for type 2 diabetes in adult people with severe mental illness
- Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
- Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
- Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus
- Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus
- Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
- Specialist nurses in diabetes mellitus
- Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis
- Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults
- Surgery for the treatment of obesity in children and adolescents
- Surgery for weight loss in adults
- Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults
- Sweet potato for type 2 diabetes mellitus
- Testosterone replacement in men with sexual dysfunction
- Thermal stability and storage of human insulin
- Thyroid hormone replacement for subclinical hypothyroidism
- Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy
- Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
- Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults
- Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults
- Vegan diet for adults with overweight or obesity
- Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy
- Vitamin D supplementation for prevention of cancer in adults
- Vitamin D supplementation for prevention of mortality in adults
- Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children
- Weight reduction for primary prevention of stroke in adults with overweight or obesity
- Whole grain foods for the prevention of type 2 diabetes mellitus
- Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
- Do school-based physical activity interventions increase moderate to vigorous physical activity and improve physical fitness among children and adolescents?
- Preventing type 2 diabetes in adults with mental health conditions in low- and middle-income countries
- Diabetes mellitus and Related Disorders (80)
- Diabetes mellitus (71)
- Diabetes mellitus - General (15)
- Type 1 Diabetes mellitus (formerly: insulin-dependent) (9)
- Type 2 Diabetes mellitus (formerly: non-insulin-dependent) (42)
- Other types of Diabetes mellitus (1)
- Latent autoimmune diabetes in adults (LADA) (1)
- Lipoatrophic Diabets mellitus (0)
- Diabetic Coma (0)
- Diabetic Ketoacidosis (1)
- Obesity in Diabetes (2)
- Pregnancy in Diabetes (see also Pregnancy and Childbirth Group) (1)
- Gestational Diabetes (1)
- Fetal Macrosomia (0)
- Diabetes Complications (2)
- Diabetic Angiopathies (see also Peripheral Vascular Disease Group, Hypertension Group, and Heart Group) (0)
- Diabetic Retinopathy (see also Eyes and Vision Group) (0)
- Diabetic Nephropathies (see also Renal Group) (1)
- Diabetic Neuropathies (see also Neuromuscular Disorders Group, and Pain, Palliative Supportive Care Group) (0)
- Diabetic Foot (see also Wounds Group) (0)
- Other neuropathies (0)
- Erectile dysfunction (1)
- Related Disorders (7)
- Glucose Intolerance (6)
- Glycosuria (0)
- Hyperglycaemia (0)
- Hypoglycaemia (1)
- Hyperinsulinaemia (0)
- Hyperinsulinism (0)
- Other Metabolic and Nutritional Disorders (43)
- Metabolic Disorders (4)
- Digestive System (0)
- Achlorhydria (0)
- Malabsorption Syndromes (0)
- Protein-Losing Enteropathies (0)
- Water, Electrolytes, Acid-Base (0)
- Water-Electrolyte Imbalance (0)
- Acid-Base Imbalance (0)
- Diabetes Insipidus (0)
- Vitamins, Minerals (0)
- Calcium Metabolism Disorders (0)
- Iron Metabolism Disorders (0)
- Phosphorus Metabolism Disorders (0)
- Hypervitaminoses (0)
- Lipids (4)
- Nutritional Disorders (39)
- Deficiency Diseases (e.g. avitaminoses. mineral deficiency, protein deficiency etc.) (10)
- Obesity (28)
- Other nutritional disorders (1)
- Other Endocrine Disorders (23)
- Non-malignant (19)
- Adrenal Gland Diseases (1)
- Pituitary Diseases (2)
- Thymus Diseases (0)
- Thyroid Diseases (13)
- Parathyroid Diseases (2)
- Hyperprolactinaemia (0)
- Dwarfism (0)
- Gonadal Disorders (1)
- Autoimmune Polyendocrinopathies (0)
- Malignant (4)
- Adrenal Neoplasms (0)
- Thyroid Neoplasms (4)
- Parathyroid Neoplasms (0)
- Pituitary Neoplasms (0)
- Thymus Neoplasms (0)
- Multiple Endocrine Neoplasia (0)
- Neoplastic Endocrine-Like Symptoms (0)
- Non-classified Metabolic or Endocrine Conditions (3)
